[en] Hypoglycaemia, hyperglycaemia and blood glucose (BG) variability are associated with worsened outcomes in critical care. However, NICE-SUGAR trial showed no clinical benefit from intensive insulin therapy. This study compares the table-based NICE-SUGAR and model-based STAR protocols to assess their relative capability to achieve safe, effective control for all patients. Validated virtual patients (n=443) were used to simulate glycaemic outcomes of the NICE-SUGAR and STAR protocols. Key outcomes evaluate tightness and safety of control for all patients: %BG in 80–144 mg/dL range (PTR); Per-Patient Mean BG (PPM_BG); and Incidence of Hypoglycaemia (BG<40 mg/dL). These metrics determine performance overall, for each patient, and safety. Results are assessed for NICE-SUGAR measuring per-protocol (~24/day) and at reported average rate (~3-hourly; ~8/day). STAR measures 1-3-hourly, averaging 12/day.
Per-protocol, STAR provided tight control, with higher PTR (90.7% vs. 78.3%) and tighter median [IQR] PPM_BG (112[106-119] vs. 117[106–137] mg/dL), and greater safety from hypoglycaemia (5 (1%) vs. 10 patients (2.5%)) compared to NICE-SUGAR simulations as per protocol. The 5-95th percentile range PPM_BG for NICE-SUGAR (97–185 mg/dL) showed ~5% of NICE-SUGAR patients had mean BG above 180mg/dL matching clinically reported performance. STAR’s 5th-90th PPM_BG percentile range was (97–146 mg/dL). Measuring as recorded clinically, NICE-SUGAR had PTR of 77%, PPM_BG of 122 [110-140] mg/dL and 24(6%) of patients experienced hypoglycaemia. These results match clinically reported values well (mean BG 115 vs. 118 mg/dL clinically vs. simulation, clinically 7% of patients had a hypoglycaemic event).
Glycaemic control protocols need to be both safe and effective for all patients before potential clinical benefits can be assessed. NICE-SUGAR clinical results do not match results expected from their protocol, and show reduced safety and performance in comparison to STAR.
Disciplines :
Engineering, computing & technology: Multidisciplinary, general & others
Author, co-author :
Uyttendaele, Vincent ; Université de Liège - ULiège > Form. doct. sc. ingé. & techno. (aéro. & mécan. - Paysage)
Dickson, Jennifer L.
Shaw, Geoffrey M.
Desaive, Thomas ; Université de Liège > Département d'astrophys., géophysique et océanographie (AGO) > Thermodynamique des phénomènes irréversibles
Chase, J. Geoffrey
Language :
English
Title :
Virtual Trials of the NICE-SUGAR Protocol: The Impact on Performance of Protocol and Protocol Compliance
Publication date :
2017
Event name :
20th World Congress of the International Federation of Automatic Control
Aragon, D., Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control. Am J Crit Care 15 (2006), 370–377.
Australia and New Zealand Intensive Care Society Clinical Trials Group, Canadian Critical Care Trials Group & The George Institute for Internation Health. 2008. The NICE-SUGAR Study [Online]. Available: https://studies.thegeorgeinstitute.org/nice/docs/PROTOCOL.pdf [Accessed 11/11/2016.
Bagshaw, S.M., Bellomo, R., Jacka, M.J., Egi, M., Hart, G.K., George, C., Committee, A.C.M., The impact of early hypoglycemia and blood glucose variability on outcome in critical illness. Crit Care, 13, 2009, R91.
Capes, S.E., Hunt, D., Malmberg, K., Gerstein, H.C., Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000), 773–778.
Chase, J.G., Andreassen, S., Jensen, K., Shaw, G.M., Impact of human factors on clinical protocol performance: a proposed assessment framework and case examples. J Diabetes Sci Technol 2 (2008), 409–416.
Chase, J.G., Le Compte, A.J., Suhaimi, F., Shaw, G.M., Lynn, A., Lin, J., Pretty, C.G., Razak, N., Parente, J.D., Hann, C.E., Preiser, J.C., Desaive, T., Tight glycemic control in critical care–the leading role of insulin sensitivity and patient variability: a review and model-based analysis. Comput Methods Programs Biomed 102 (2011), 156–171.
Chase, J.G., Pretty, C.G., Pfeifer, L., Shaw, G.M., Preiser, J.C., Le Compte, A.J., Lin, J., Hewett, D., Moorhead, K.T., Desaive, T., Organ failure and tight glycemic control in the SPRINT study. Crit Care, 14, 2010, R154.
Chase, J.G., Shaw, G., Le Compte, A., Lonergan, T., Willacy, M., Wong, X.W., Lin, J., Lotz, T., Lee, D., Hann, C., Implementation and evaluation of the SPRINT protocol for tight glycaemic control in critically ill patients: a clinical practice change. Crit Care, 12, 2008, R49.
Chase, J.G., Suhaimi, F., Penning, S., Preiser, J.C., Le Compte, A.J., Lin, J., Pretty, C.G., Shaw, G.M., Moorhead, K.T., Desaive, T., Validation of a model-based virtual trials method for tight glycemic control in intensive care. Biomed Eng Online, 9, 2010, 84.
Egi, M., Bellomo, R., Stachowski, E., French, C.J., Hart, G.K., Taori, G., Hegarty, C., Bailey, M., Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc 85 (2010), 217–224.
Evans, A., Le Compte, A., Tan, C.S., Ward, L., Steel, J., Pretty, C.G., Penning, S., Suhaimi, F., Shaw, G.M., Desaive, T., Chase, J.G., Stochastic targeted (STAR) glycemic control: design, safety, and performance. J Diabetes Sci Technol 6 (2012), 102–115.
Finfer, S., Chittock, D.R., Su, S.Y., Blair, D., Foster, D., Dhingra, V., Bellomo, R., Cook, D., Dodek, P., Henderson, W.R., Hebert, P.C., Heritier, S., Heyland, D.K., Mcarthur, C., Mcdonald, E., Mitchell, I., Myburgh, J.A., Norton, R., Potter, J., Robinson, B.G., Ronco, J.J., Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009), 1283–1297.
Finfer, S., Liu, B., Chittock, D.R., Norton, R., Myburgh, J.A., Mcarthur, C., Mitchell, I., Foster, D., Dhingra, V., Henderson, W.R., Ronco, J.J., Bellomo, R., Cook, D., Mcdonald, E., Dodek, P., Hebert, P.C., Heyland, D.K., Robinson, B.G., Hypoglycemia and risk of death in critically ill patients. N Engl J Med 367 (2012), 1108–1118.
Fisk, L.M., Le Compte, A.J., Shaw, G.M., Penning, S., Desaive, T., Chase, J.G., STAR development and protocol comparison. IEEE Trans Biomed Eng 59 (2012), 3357–3364.
Griesdale, D.E., De Souza, R.J., Van Dam, R.M., Heyland, D.K., Cook, D.J., Malhotra, A., Dhaliwal, R., Henderson, W.R., Chittock, D.R., Finfer, S., Talmor, D., Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180 (2009), 821–827.
Hann, C.E., Chase, J.G., Lin, J., Lotz, T., Doran, C.V., Shaw, G.M., Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Programs Biomed 77 (2005), 259–270.
Holzinger, U., Feldbacher, M., Bachlechner, A., Kitzberger, R., Fuhrmann, V., Madl, C., Improvement of glucose control in the intensive care unit: an interdisciplinary collaboration study. Am J Crit Care 17 (2008), 150–156.
Krinsley, J., Glucose control reduces ICU stay and mortality. Perform Improv Advis 9:1 (2005), 4–6.
Krinsley, J.S., Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78 (2003), 1471–1478.
Krinsley, J.S., Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004), 992–1000.
Krinsley, J.S., Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol 3 (2009), 1292–1301.
Krinsley, J.S., Preiser, J.C., Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit Care, 19, 2015, 179.
Lin, J., Lee, D., Chase, J.G., Shaw, G.M., Le Compte, A., Lotz, T., Wong, J., Lonergan, T., Hann, C.E., Stochastic modelling of insulin sensitivity and adaptive glycemic control for critical care. Comput Methods Programs Biomed 89 (2008), 141–152.
Lin, J., Razak, N.N., Pretty, C.G., Le Compte, A., Docherty, P., Parente, J.D., Shaw, G.M., Hann, C.E., Geoffrey Chase, J., A physiological Intensive Control Insulin-Nutrition-Glucose (ICING) model validated in critically ill patients. Comput Methods Programs Biomed 102 (2011), 192–205.
Marik, P.E., Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!. Intensive Care Med 42 (2016), 1475–1477.
Mccowen, K.C., Malhotra, A., Bistrian, B.R., Stress-induced hyperglycemia. Crit Care Clin 17 (2001), 107–124.
Mesotten, D., Van Den Berghe, G., Clinical benefits of tight glycaemic control: focus on the intensive care unit. Best Pract Res Clin Anaesthesiol 23 (2009), 421–429.
Penning, S. 2014. Tight Glycaemic Control : Model-based methods to answer critical questions about this controversial therapy. PhD, University of Liège.
Penning, S., Chase, J.G., Preiser, J.C., Pretty, C.G., Signal, M., Melot, C., Desaive, T., Does the achievement of an intermediate glycemic target reduce organ failure and mortality? A post hoc analysis of the Glucontrol trial. J Crit Care 29 (2014), 374–379.
Penning, S., Pretty, C., Preiser, J.C., Shaw, G.M., Desaive, T., Chase, J.G., Glucose control positively influences patient outcome: A retrospective study. J Crit Care 30 (2015), 455–459.
Preiser, J.C., Devos, P., Ruiz-Santana, S., Melot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., Chiolero, R., A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 35 (2009), 1738–1748.
Preiser, J.C., Straaten, H.M., Glycemic control: please agree to disagree. Intensive Care Med 42 (2016), 1482–1484.
Signal, M., Le Compte, A., Shaw, G.M., Chase, J.G., Glycemic levels in critically ill patients: are normoglycemia and low variability associated with improved outcomes?. J Diabetes Sci Technol 6 (2012), 1030–1037.
Stewart, K.W., Pretty, C.G., Tomlinson, H., Thomas, F.L., Homlok, J., Noemi, S.N., Illyes, A., Shaw, G.M., Benyo, B., Chase, J.G., Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis. Ann Intensive Care, 6, 2016, 24.
Van Den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P.J., Milants, I., Van Wijngaerden, E., Bobbaers, H., Bouillon, R., Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006), 449–461.
Van Den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., Bouillon, R., Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001), 1359–1367.
Van Den Berghe, G., Wouters, P.J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31 (2003), 359–366.
Van Den Berghe, G., Wouters, P.J., Kesteloot, K., Hilleman, D.E., Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med 34 (2006), 612–616.
Wiener, R.S., Wiener, D.C., Larson, R.J., Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300 (2008), 933–944.